Filing Details

Accession Number:
0001181431-13-014206
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-03-04 19:41:01
Reporting Period:
2013-02-28
Filing Date:
2013-03-04
Accepted Time:
2013-03-04 19:41:01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1401923 Map Pharmaceuticals Inc. MAPP Pharmaceutical Preparations (2834) 200507047
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1413822 Anastasios Gianakakos 2400 Bayshore Parkway, Suite 200
Mountain View CA 94043
Svp, Chief Business Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-02-28 20,000 $10.37 38,438 No 4 M Direct
Common Stock Disposition 2013-02-28 20,000 $25.00 18,438 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Acquisiton 2013-02-28 20,000 $0.00 20,000 $10.37
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
50,000 2019-02-10 No 4 M Direct
Footnotes
  1. The transaction was made pursuant to a 10b5-1 trading plan in effect at the time of the transaction.
  2. Fully exercisable.